Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Capodanno
Stephan Windecker

Showing results (71-80 of 2,159) with videos related to

Pageof 216
Sort By:
Progress in Cardiovascular Diseases|February 26, 2026
Prehabilitation in frail patients undergoing cardiac valve interventionLuigi Cutore, Davide Capodanno
Giornale Italiano Di Cardiologia (2006)|February 25, 2026
[Factor XI inhibition in atrial fibrillation: where do we stand?]Simona Giubilato, Davide Capodanno
European Heart Journal. Quality of Care & Clinical Outcomes|November 20, 2018
Drug-eluting stents are not alike: does it matter?Giulio Guagliumi, Davide Capodanno
JACC. Cardiovascular Interventions|April 3, 2022
Culprit Lesions Phenotypes in ST-Segment Elevation Acute Coronary Syndromes: A Call for Precision MedicineDavide Capodanno, Claudio Laudani
European Heart Journal Supplements : Journal of the European Society of Cardiology|October 15, 2021
Reflections after TWILIGHT study: a new era in secondary prevention without aspirin?Giovanni Occhipinti, Davide Capodanno
Expert Review of Cardiovascular Therapy|May 8, 2009
Evolution of stents: past, present and futureCorrado Tamburino, Davide Capodanno
JACC. Asia|March 6, 2023
Shortening Dual Antiplatelet Therapy Duration in High-Risk Patients Undergoing Percutaneous Coronary InterventionAntonio Greco, Davide Capodanno
JACC. Cardiovascular Interventions|May 29, 2024
Rethinking Aspirin: Ditching the Daily "Pill"ar of TraditionSimone Finocchiaro, Davide Capodanno
Thrombosis and Haemostasis|April 25, 2025
Factor XI Inhibitors for Myocardial Infarction: A Safer Path to Thrombotic Protection?Marco Spagnolo, Davide Capodanno
Expert Review of Cardiovascular Therapy|March 9, 2013
Dual antiplatelet therapy in patients with diabetes mellitus: special considerationsPiera Capranzano, Davide Capodanno
Pageof 216

Showing results (71-80 of 2,159) with videos related to

Sort By:
Pageof 216
Progress in Cardiovascular Diseases|February 26, 2026
Prehabilitation in frail patients undergoing cardiac valve interventionLuigi Cutore, Davide Capodanno
Giornale Italiano Di Cardiologia (2006)|February 25, 2026
[Factor XI inhibition in atrial fibrillation: where do we stand?]Simona Giubilato, Davide Capodanno
European Heart Journal. Quality of Care & Clinical Outcomes|November 20, 2018
Drug-eluting stents are not alike: does it matter?Giulio Guagliumi, Davide Capodanno
JACC. Cardiovascular Interventions|April 3, 2022
Culprit Lesions Phenotypes in ST-Segment Elevation Acute Coronary Syndromes: A Call for Precision MedicineDavide Capodanno, Claudio Laudani
European Heart Journal Supplements : Journal of the European Society of Cardiology|October 15, 2021
Reflections after TWILIGHT study: a new era in secondary prevention without aspirin?Giovanni Occhipinti, Davide Capodanno
Expert Review of Cardiovascular Therapy|May 8, 2009
Evolution of stents: past, present and futureCorrado Tamburino, Davide Capodanno
JACC. Asia|March 6, 2023
Shortening Dual Antiplatelet Therapy Duration in High-Risk Patients Undergoing Percutaneous Coronary InterventionAntonio Greco, Davide Capodanno
JACC. Cardiovascular Interventions|May 29, 2024
Rethinking Aspirin: Ditching the Daily "Pill"ar of TraditionSimone Finocchiaro, Davide Capodanno
Thrombosis and Haemostasis|April 25, 2025
Factor XI Inhibitors for Myocardial Infarction: A Safer Path to Thrombotic Protection?Marco Spagnolo, Davide Capodanno
Expert Review of Cardiovascular Therapy|March 9, 2013
Dual antiplatelet therapy in patients with diabetes mellitus: special considerationsPiera Capranzano, Davide Capodanno
Pageof 216